undamentalytics Newsletter

Arvinas, Inc. balance sheet

At the end of fiscal 2025, Arvinas, Inc. had total assets of $718m, total liabilities of $284m and shareholders' equity of $434m. It held $143m in cash against $600,000 of debt: net cash of $142m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Arvinas, Inc.: balance sheet, annual
Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents31395881088131210114394
Receivables253—115106150
Total current assets661962917031,5531,2401,2801,067701652
Total assets671993027171,5821,2691,3051,091718675
Accounts payable13573161813248
Deferred revenue (current)14162022206219163156710
Total current liabilities1823334926229525723014383
Short-term debt00———00000
Long-term debt0222111100
Total debt0222111111
Total liabilities67637575800704645530284113
Shareholders' equity−61137227642782565660562434562
Non-controlling interests and other (assets − liabilities − equity)61—————————
Net debt (negative = net cash)−31−1−7−586−107−80−311−100−142−94
Shares outstanding——38m49m53m53m68m69m64m65m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ARVN vs IOVAADPT vs ARVNARVN vs VCELARVN vs VIR

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Arvinas, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Arvinas, Inc.